✦ LIBER ✦

72 Gefitinib in patients affected by non small cell lung cancer(NSCLC): Symptomatic improvement within few days

✍ Scribed by Bearz, A.; Vaccher, E.; Simon, S.; Michele, S.; Massimiliano, B.; Umberto, T.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gefitinib in patients with non-small cel

✍ Bearz, A.; Vaccher, E.; Spazzapan, S.; Berretta, M.; Tirelli, U. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Erlotinib in patient with non-small cell

✍ Garfield, D.; Kashef, G. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 58 KB

130PD ERLOTINIB RELATED TOXICITY IN ELDE

✍ Palazzo, A.; Iacovelli, R.; Mazzoli, M.; Mancini, M.L.; Passaro, A.; Altavilla, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 42 KB

795 Vinorelbin (VNB) and gemcitabine (ge

✍ P. Amadio; D. Priolo; G. Antonelli; S. Cali; P. Colina; M. Mattina; F. Vitale; F 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 169 KB

919 Clinically meaningful improvement in

✍ J.-Y. Douillard; D. Cella; R.B. Natale; T.J. Lynch; C. Lee; D. Carbone; A. Kay; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 316 KB

683k: Minimally Invasive Selective Sampl

✍ James Callaway; Ayesha S. Bryant; Robert J. Cerfolio; Whitney Jennings; Mohamad 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 87 KB